Schuurman, J.L.* ; van Tetering, L.* ; Houthuijs, K.J.* ; Kooijman, P.* ; Gailus-Durner, V. ; Leuchtenberger, S. ; Fuchs, H. ; Hrabě de Angelis, M. ; Engelke, U.F.H.* ; Lefeber, D.J.* ; van Karnebeek, C.D.M.* ; Wevers, R.A.* ; Grgic, A.* ; Balluf, B.* ; Vandenbosch, M.* ; Vreeken, R.* ; Heeren, R.M.A.* ; Berden, G.* ; Oomens, J.* ; Martens, J.W.M.*
Structure elucidation for MALDI mass spectrometry imaging using infrared ion spectroscopy.
Anal. Chem., DOI: 10.1021/acs.analchem.5c00948 (2025)
Infrared ion spectroscopy (IRIS) is a tandem mass spectrometry (MS) technique that generates structurally diagnostic vibrational spectra for mass-selected ions trapped in a mass spectrometer. Until now, IRIS applications for biological samples have primarily focused on solution-based analyses, such as body fluids (e.g., plasma and urine) and tissue homogenates, using electrospray ionization (ESI) coupled with liquid chromatography-mass spectrometry (LC-MS). In this study, we have combined matrix-assisted laser desorption/ionization (MALDI) with IRIS for the direct analysis of small molecules from biological tissues on a Fourier-transform ion cyclotron resonance mass spectrometer. We applied this technique alongside MALDI mass spectrometry imaging to analyse brain tissue from two knockout mouse models of l-lysine catabolism disorders: pyridoxine-dependent epilepsy (ALDH7A1) and glutaric aciduria type 1 (GCDH). The MALDI-IRIS platform, now available for users at HFML-FELIX, represents a significant advance in the direct structural characterization of metabolites in complex biological tissues and opens new possibilities for structure elucidation in the field of MALDI mass spectrometry imaging.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Typ der Hochschulschrift
Herausgeber
Schlagwörter
Pyridoxine-dependent Epilepsy; Ultraviolet-laser Desorption; Mouse Model; Brain; Ionization; Metabolism; Biomarkers; Antiquitin
Keywords plus
Sprache
englisch
Veröffentlichungsjahr
2025
Prepublished im Jahr
0
HGF-Berichtsjahr
2025
ISSN (print) / ISBN
0003-2700
e-ISSN
1520-6882
ISBN
Bandtitel
Konferenztitel
Konferzenzdatum
Konferenzort
Konferenzband
Quellenangaben
Band:
Heft:
Seiten:
Artikelnummer:
Supplement:
Reihe
Verlag
American Chemical Society (ACS)
Verlagsort
1155 16th St, Nw, Washington, Dc 20036 Usa
Tag d. mündl. Prüfung
0000-00-00
Betreuer
Gutachter
Prüfer
Topic
Hochschule
Hochschulort
Fakultät
Veröffentlichungsdatum
0000-00-00
Anmeldedatum
0000-00-00
Anmelder/Inhaber
weitere Inhaber
Anmeldeland
Priorität
Begutachtungsstatus
Peer reviewed
POF Topic(s)
30201 - Metabolic Health
Forschungsfeld(er)
Genetics and Epidemiology
PSP-Element(e)
G-500600-001
Förderungen
NWO Rekentijd grant
Dutch Research Council (NWO)
Changing Rare Disorders of Lysine Metabolism (CHARLIE) consortium
Copyright
Erfassungsdatum
2025-06-23